Viral Infections in Immunocompromised Patients

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 1 SUPPL, 2011, Pages

  Englund, Janet ^a   Feuchtinger, Tobias ^b   Ljungman, Per ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; CYTOMEGALOVIRUS VACCINE; GAMMA INTERFERON; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; SIALIDASE INHIBITOR;

ADENOVIRUS INFECTION; ADOPTIVE IMMUNOTHERAPY; ANTIVIRAL THERAPY; ARTICLE; CELL THERAPY; CHICKENPOX; COMMUNICABLE DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CORONAVIRUS; DRUG EFFICACY; DRUG SAFETY; ENDEMIC DISEASE; EPSTEIN BARR VIRUS; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; LOWER RESPIRATORY TRACT INFECTION; MEASLES; MUMPS; PARAINFLUENZA VIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; RUBELLA; SEASONAL VARIATION; T CELL DEPLETION; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VIREMIA; VIRUS INFECTION; VIRUS LOAD; VIRUS VIRULENCE; WART VIRUS;

COMMUNITY-ACQUIRED INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOTHERAPY, ADOPTIVE; VACCINATION; VIRUS DISEASES;

EID: 78650674286     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.11.008     Document Type: Article

References (32)

1. Peret T.C., Boivin G., Li Y., et al. Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis 2002, 185:1660-1663.
2. Boivin G., Abed Y., Pelletier G., et al. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis 2002, 186:1330-1334.
3. Milano F., Campbell A.P., Guthrie K.A., Kuypers J., et al. Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients. Blood 2010, 115:2088-2094.
4. Schenk T., Strahm B., Kontny U., Hufnagel M., Neumann-Haefelin D., Falcone V. Disseminated bocavirus infection after stem cell transplant. Emerg Infect Dis 2007, 13:1425-1427.
5. Harrington R.D., Hooton T.M., Hackman R.C., et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992, 165:987-993.
6. Raad I., Abbas J., Whimbey E. Infection control of nosocomial respiratory viral disease in the immunocompromised host. Am J Med 1997, 102:48-52. discussion 3-4.
7. Bowden R. Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience. Am J Med 1997, 102:27-30.
8. Fan J., Henrickson K.J., Savatski L.L. Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex). Clin Infect Dis 1998, 26:1397-1402.
9. Templeton K.E., Scheltinga S.A., van den Eeden W.C., Graffelman A.W., van den Broek P.J., Claas E.C. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 2005, 41:345-351.
10. Khanna N., Widmer A.F., Decker M., Steffen I., Halter J., Heim D., et al. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis 2008, 46:402-412.
11. Sparrelid E., Ljungman P., Ekelof-Andstrom E., et al. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant 1997, 19:905-908.
12. Frank J.A., Warren R.W., Tucker J.A., Zeller J., Wilfert C.M. Disseminated parainfluenza infection in a child with severe combined immunodeficiency. Am J Dis Child 1983, 137:1172-1174.
13. Piedra P., Englund J., Glezen P. Respiratory synctal virus and parainfluenza viruses. Clinical Virology 1997, 718-819. Churchill Livingstone, New York. F.W.R. Hayden (Ed.).
14. van Tol M.J., Kroes A.C., Schinkel J., et al. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant 2005, 36:39-50.
15. Chatziandreou I., Gilmour K.C., McNicol A.M., et al. Capture and generation of adenovirus specific T cells for adoptive immunotherapy. Br J Haematol 2007, 136:117-126.
16. Feuchtinger T., Richard C., Joachim S., et al. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation. J Immunother 2008, 31:199-206.
17. Feuchtinger T., Matthes-Martin S., Richard C., et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2006, 134:64-76.
18. Whimbey E., Elting L.S., Couch R.B., et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 1994, 13:437-440.
19. Ljungman P., Ward K.N., Crooks B.N., et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001, 28:479-484.
20. Machado C.M., Boas L.S., Mendes A.V., et al. Use of Oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 2004, 34:111-114.
21. Nichols W.G., Guthrie K.A., Corey L., Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004, 39:1300-1306.
22. Engelhard D., Nagler A., Hardan I., et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993, 11:1-5.
23. Pauksen K., Linde A., Hammarstrom V., et al. Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin Infect Dis 2000, 30:342-348.
24. Machado C.M., Cardoso M.R., da Rocha I.F., Boas L.S., Dulley F.L., Pannuti C.S. The benefit of influenza vaccination after bone marrow transplantation. Bone Marrow Transplant 2005, 36:897-900.
25. Avetisyan G., Aschan J., Hassan M., Ljungman P. Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation. Transplantation 2008, 86:257-263.
26. Murasko D.M., Bernstein E.D., Gardner E.M., et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 2002, 37:427-439.
27. Ljungman P., Nahi H., Linde A. Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Br J Haematol 2005, 130:96-98.
28. Ljungman P., Cordonnier C., Einsele H., et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009, 44:521-526.
29. Nakano T., Shimono Y., Sugiyama K., et al. Clinical features of measles in immunocompromised children. Acta Paediatr Jpn 1996, 38:212-217.
30. Kaplan L., Daum R., Smaron M., McCarthy C. Severe measles in immunocompromised patients. JAMA 1992, 267:1237-1241.
31. Ljungman P., Fridell E., Lönnqvist B., et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989, 159:610-615.
32. Machado C.M., Goncalves F.B., Pannuti C.S., Dulley F.L., de Souza V.A. Measles in bone marrow transplant recipients during an outbreak in Sao Paulo. Brazil. Blood 2002, 99:83-87.